SleepNow Study Overview
The SleepNow study focused on men with metastatic prostate cancer (mPCa) who struggle with insomnia. It tested a new program that combines cognitive behavioral therapy for insomnia (CBT-I) with physical exercise.
Study Details
- Participants: 12 men undergoing treatment for castration-resistant mPCa with insomnia.
- Method: Patients were divided into two groups: one received the SleepNow program, and the other received usual care.
- Program Duration: 12 weeks, including bi-weekly exercise sessions and four nurse-led CBT-I sessions.
- Assessment: Feasibility and outcomes were measured at the start and after 3 months.
Results
- High satisfaction among participants in the intervention group.
- 75% attended at least three CBT-I sessions, and four completed most exercise sessions.
- Improvements were noted in insomnia, sleep quality, fatigue, anxiety, depression, and overall quality of life.
- However, differences between the two groups were not statistically significant.
Conclusion
The SleepNow intervention is the first of its kind to combine nurse-led CBT-I with physical exercise. It was well-received and shows promise for helping patients with metastatic cancer manage sleep issues.
Importance of Clinical Trials
Clinical trials are essential for creating safe and effective treatments. We need to integrate these findings into everyday healthcare.
Introducing DocSym
DocSym is an AI-powered platform that brings together ICD-11 standards, clinical protocols, and research into one easy-to-use resource for healthcare providers.
Streamlining Healthcare Operations
Our mobile apps assist with scheduling, treatment monitoring, and telemedicine, simplifying patient care management and expanding digital services.
Enhancing Patient Outcomes
By leveraging AI, clinics can improve workflows, enhance patient outcomes, and reduce reliance on paper processes. Discover more at aidevmd.com.
